ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1022

Abuse in Rheumatic Diseases: Associations with Depression, Disability, and Psychosocial Risk Factors

Margarita Isabel Alarcon-Jarquin1, Egla Samantha Sanchez-Peralta2, Maria Eugenia Corral-Trujillo3, Daniela Alejandra Salcedo-Soto4, Judith Michelle Ramirez-Alonso4, Ana Elena González-Rosales5, Juan Daniel Valdez-Cruz4, Osmel Adrián Ramirez-Uzcategui4, Jesús Gilberto Espinoza-Gámez6, Yessica Rubi Reyes-Yepiz14, Juan Pablo González-Morales4, Virginia Pascual-Ramos7, Dionicio A. Galarza-Delgado8, Gabriel Figueroa-Parra9 and Diana E. Flores-Alvarado2, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, México, Monterrey, Nuevo Leon, Mexico, 3Universidad Autónoma de Nuevo León, Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, México., Monterrey, Nuevo Leon, Mexico, 4Hospital universitario José Eleuterio González, Monterrey, Nuevo Leon, Mexico, 5Hospital universitario José Eleuterio González, Monterrey, Mexico, 6Rheumatology Service, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo Leon, Mexico, 7Rheumatology Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico, Mexico City, Distrito Federal, Mexico, 8Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 9Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico

Meeting: ACR Convergence 2025

Keywords: Anxiety, depression, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1007–1037) Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Exposure to a hostile environment may negatively impact disease outcomes in patients with RD, particularly by affecting their mental health and overall quality of life. We aimed to evaluate the prevalence of abuse among patients with RD and to identify their associated factors.

Methods: We conducted a cross-sectional study at an academic rheumatology clinic, including adult patients with a clinical diagnosis of RD. A modified version of the Geriatric Mistreatment Scale was used to assess physical, psychological, neglect, economic, and sexual abuse. Psychological symptoms (DASS-21 tool), personality traits (BFI-10), functional capacity (HAQ-DI) disease activity (RAPID-3), family function (APGAR questionnaire), resilience (BRCS), and quality of life (WHOQOL-BREF) were all assessed. Patients were grouped based on reported abuse. Group comparisons were performed using X2 and Mann–Whitney U tests. Univariable logistic regression was conducted to explore associations between abuse and clinical or psychosocial factors. Multivariable logistic regression was used to account for age, sex, education level, and marital status. P< 0.05 was statistically significant.

Results: We included 250 patients with RD. Median age was 52 years (IQR 44–61), and 232 (92.8%) were female. Most patients had RA (124, 49.6%), followed by SLE (50, 20.0%), and SS (20, 8.0%). The prevalence of abuse/mistreatment was 39.8% (n= 98). There were no differences in age, sex, educational level, economic status, or employment status between patients with or without abuse (Table 1). Patients with abuse had more functional disability (34.0%) than non-abuse patients (13.2%; p< 0.001), and fewer patients with RA and abuse were on remission according to RAPID3 (46.9% vs. 65.8%, p< 0.005). Quality of life was lower among patients with abuse in the psychological, social, and environmental domains; but not in the physical domain (Table 2). In univariable logistic regression, mistreatment was associated with higher levels of depression (OR 1.10, 95% CI 1.05–1.14), anxiety (OR 1.09, 95% CI 1.05–1.13), stress (OR 1.09, 95% CI 1.06–1.13), and disability (OR 2.10, 95% CI 1.40–3.10). It was also associated with lower quality of life (psychological, social, and environmental), higher neuroticism, and reduced coping and family function (Table 3). After accounting for age, sex, education and marital status, abuse/mistreatment remained associated with higher levels of depression (aOR 1.10, 95% CI 1.05–1.15), anxiety (aOR 1.09, 95% CI 1.05–1.13), stress (aOR 1.10, 95% CI 1.06–1.13), and disability (aOR 2.10, 95% CI 1.40–3.10). In contrast, better quality of life (psychological, social, and environmental), along with lower neuroticism (aOR 0.83, 95% CI 0.72–0.96), adaptive coping (aOR 0.89, 95% CI 0.81–0.97), and stronger family support (aOR, 95% CI 0.67–0.87), were protective (Table 3).

Conclusion: Abuse in patients with RD is associated with greater psychological distress, disability, and disease activity, while better quality of life, coping, and family support are protective. Screening for abuse should be considered in patients care to improve outcomes.

Supporting image 1Table 1. Sociodemographic, clinical, and psychosocial characteristics of patients with rheumatic diseases with and without abuse/mistreatment.

Supporting image 2Table 2. Clinical, psychological, and quality of life characteristics of patients with rheumatic diseases with and without abuse.

Supporting image 3Table 3. Factors associated with abuse among patients with rheumatic diseases.


Disclosures: M. Alarcon-Jarquin: None; E. Sanchez-Peralta: None; M. Corral-Trujillo: None; D. Salcedo-Soto: None; J. Ramirez-Alonso: None; A. González-Rosales: None; J. Valdez-Cruz: None; O. Ramirez-Uzcategui: None; J. Espinoza-Gámez: None; Y. Reyes-Yepiz1: None; J. González-Morales: None; V. Pascual-Ramos: None; D. Galarza-Delgado: None; G. Figueroa-Parra: None; D. Flores-Alvarado: None.

To cite this abstract in AMA style:

Alarcon-Jarquin M, Sanchez-Peralta E, Corral-Trujillo M, Salcedo-Soto D, Ramirez-Alonso J, González-Rosales A, Valdez-Cruz J, Ramirez-Uzcategui O, Espinoza-Gámez J, Reyes-Yepiz1 Y, González-Morales J, Pascual-Ramos V, Galarza-Delgado D, Figueroa-Parra G, Flores-Alvarado D. Abuse in Rheumatic Diseases: Associations with Depression, Disability, and Psychosocial Risk Factors [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/abuse-in-rheumatic-diseases-associations-with-depression-disability-and-psychosocial-risk-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abuse-in-rheumatic-diseases-associations-with-depression-disability-and-psychosocial-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology